Fragility Fractures as the Initial Manifestation of Indolent Systemic Mastocytosis

Endocrine Abstracts
doi 10.1530/endoabs.37.ep303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Efficacy of Omalizumab in Indolent Systemic Mastocytosis

Case Reports in Hematology
2019English

Delayed Diagnosis of Adult Indolent Systemic Mastocytosis

Dermatology Reports
Dermatology
2014English

Endoscopic Findings of Indolent Systemic Mastocytosis Involving the Colon

Endoscopy
Gastroenterology
2014English

Digital Ulcers as an Initial Manifestation of Systemic Lupus Erythematosus

Internal Medicine
Internal MedicineMedicine
2011English

Smouldering Mastocytosis: Survival Comparisons With Indolent and Aggressive Mastocytosis

American Journal of Hematology
Hematology
2018English

Systemic Mastocytosis Presenting as Recurrent, Refractory Anaphylaxis

Pathology
Forensic MedicinePathology
2020English

Systemic Mastocytosis

2020English

Masitinib for Treatment of Severely Symptomatic Indolent Systemic Mastocytosis: A Randomised, Placebo-Controlled, Phase 3 Study

The Lancet
Medicine
2017English

Masitinib for Treatment of Severely Symptomatic Indolent Systemic Mastocytosis: A Randomised, Placebo-Controlled, Phase 3 Study

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy